This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Novo Nordisk A/S (NVO)

NYSE: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 2.48B 2.35B 2.03B 0.00
Receivables 3.17B 2.86B 2.81B 2.41B
Inventories 1.87B 1.85B 1.77B 1.69B
Other Current Assets 44.53M 45.88M 281.52M 165.01M
Total Current Assets 8.08B 7.56B 7.78B 7.12B
Property, Plant & Equipment, Gross 3.74B 7.75B 8.15B 7.55B
Accumulated Depreciation & Depletion n.a. 3.98B 4.10B 3.73B
Property, Plant & Equipment, Net 3.74B 3.78B 4.05B 3.82B
Intangibles 316.10M 224.99M 298.92M 264.97M
Other Non-Current Assets 314.93M 139.76M 101.98M 40.41M
Total Non-Current Assets 5.37B 5.02B 5.23B 4.52B
Liabilities & Shareholder Equity
Total Assets 13.45B 12.58B 13.02B 11.64B
Accounts Payable 721.71M 1.62B 757.39M 683.97M
Short Term Debt 157.17M 117.55M 39.79M 88.62M
Other Current Liabilities 5.11B 3.02B 3.69B 3.06B
Total Current Liabilities 5.99B 5.50B 4.48B 3.84B
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 878.88K 1.14M 124.38M 129.74M
Other Non-Current Liabilities 578.74M 501.57M 531.39M 472.70M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 579.62M 502.71M 655.77M 602.44M
Total Liabilities 6.57B 6.00B 5.14B 4.44B
Preferred Stock Equity n.a. 0.00 0.00 0.00
Common Stock Equity 6.88B 6.58B 7.88B 7.20B
Common Par 76.17M 86.53M 101.80M 99.25M
Additional Paid In Capital 0.00 0.00 0.00 0.00
Cumulative Translation Adjustment n.a. 0.00 0.00 0.00
Retained Earnings 6.86B 6.74B 7.61B 6.91B
Treasury Stock -1.46M -1.80M -3.89M -3.01M
Other Equity Adjustments -52.29M -245.23M 167.14M 192.84M
Total Capitalization 6.88B 6.58B 7.88B 7.20B
Total Equity 6.88B 6.58B 7.88B 7.20B
Total Liabilities & Stock Equity 13.45B 12.58B 13.02B 11.64B
Total Common Shares Outstanding 2.60B 2.65B 2.75B 2.37B
Preferred Shares n.a. 0.00 0.00 0.00
Treasury Shares n.a. 57.00M 0.00 425.00M
Basic Weighted Shares Outstanding n.a. 2.62B 2.68B 2.74B
Diluted Weighted Shares Outstanding n.a. 2.63B 2.69B 2.76B
Number of Employees 41000 NA NA 34286
Number of Part-Time Employees NA NA NA 0
NVO News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

NVO Novo Nordisk A/S

Chart of NVO

Analysts Ratings for NVO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET NVO ANALYST REPORT

NVO Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs